Related Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Quality-Control Analytical Methods: Pharmaceutical and Analytical Considerations of the Significance of pH
Vu Nicole, Miller Misty
|
May/Jun 2009
Pg. 230-232
|
Quality-Control Analytical Methods: Principles of pH
Allen Loyd V Jr
|
May/Jun 2003
Pg. 225-227
View Sample |
Quality-Control Analytical Methods: Selecting an Analytical Method
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 61-64
|
Quality-Control Analytical Methods: High-Performance Liquid Chromatography
Kupiec Thomas C
|
May/Jun 2004
Pg. 223-227
|
Quality-Control Analytical Methods: Gas Chromatography
Kupiec Thomas C
|
Jul/Aug 2004
Pg. 305-309
|
Quality Control Analytical Methods: Method Validation
Klang Mark G, Williams LaVonn A
|
Sep/Oct 2016
Pg. 381-386
|
Quality-Control Analytical Methods: Osmolality and Osmometry
Allen Loyd V Jr
|
Mar/Apr 2004
Pg. 143-145
|
Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding
Kupiec Thomas C, Okeke Claudia, Allen Loyd V Jr, Denison Clay
|
Jul/Aug 2005
Pg. 300-302
|
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds
Trusley Craig
|
Nov/Dec 2007
Pg. 487-490
|
Quality-Control Analytical Methods: Specific-Gravity Determinations of Liquids and Semisolids
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 477-480
|
Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
|
Nov/Dec 2015
Pg. 453-463
|
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Zolner William J
|
Jul/Aug 2006
Pg. 281-284
|
Quality Control Analytical Methods: Continuous Quality Improvement
Venti Eden M
|
Nov/Dec 2006
Pg. 442-444
|
Quality-Control Analytical Methods: Designing a Quality-Control Potency Testing Program for a Compounding Pharmacy
Zolner William J
|
Sep/Oct 2009
Pg. 412-418
|
Quality-Control Analytical Methods: Viscosity Measurements
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 305-309
|
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L, Kokki H, Rasi A S, Naaranlahti Toivo J
|
Nov/Dec 2002
Pg. 471-474
|
Quality Control Analytical Methods: The Quality of Sterility Testing
McGuire Jason, Kupiec Thomas C
|
Jan/Feb 2007
Pg. 52-55
|
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia, Connors Anne
|
Mar/Apr 2013
Pg. 130-134
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006
Pg. 202-204
|
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Kupiec Thomas C
|
Sep/Oct 2007
Pg. 400-403
|
Quality-Control Analytical Methods: Homogeneity of Dosing Forms
Kupiec Thomas C, Vu Nicole, Branscum David
|
Jul/Aug 2008
Pg. 340-343
|
Quality Control Analytical Methods: Common Concerns about Out-of-Specification Results
Lanier Lance, Kemp Jesse
|
Jan/Feb 2006
Pg. 41-42
|
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 123-130
|
Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 462-469
|
Quality Control Analytical Methods: Continuous Quality Improvement
Odegard Russell D
|
May/Jun 2010
Pg. 218-221
|
pH and Osmolarity, A Review of
Stranz Marc, Kastango Eric S
|
May/Jun 2002
Pg. 216-220
|
Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care?
Cabaleiro Joe
|
Jul/Aug 2009
Pg. 318-320
|
PostScription: Challenges Facing an Analytical Laboratory
Kupiec Thomas C
|
Nov/Dec 2006
Pg. 479-480
|
Quality-Control Analytical Methods: Sterility Failure Investigations
Venti Eden M
|
Sep/Oct 2006
Pg. 372-375
|
Quality-control Analytical Methods: Logbooks and Documentation Forms
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 306-311
|
Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method
Kupiec Thomas C, Skinner Rodney, Lanier Lance
|
Jan/Feb 2008
Pg. 50-53
|
Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
|
Jan/Feb 2009
Pg. 53-55
|
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
|
Nov/Dec 2008
Pg. 524-528
|
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations
Kupiec Thomas C
|
Jan/Feb 2005
Pg. 47-49
|
Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations
Kupiec Thomas C
|
Mar/Apr 2005
Pg. 136-138
|
Quality-Control Analytical Methods: Determination of Tapped Bulk Volume for Compounded Prescriptions
Al-Achi Antoine, Siddoju Srujana
|
May/Jun 2005
Pg. 207
|
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Allen Loyd V Jr
|
May/Jun 2013
Pg. 210-219
|
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013
Pg. 485-489
|
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Vu Nicole, Lou Jessica R, Kupiec Thomas
|
May/Jun 2014
Pg. 213-221
|
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1
Dubczak John, Latta Kenneth S, Hedman Hilary, Smith Donald R
|
Sep/Oct 2010
Pg. 407-414
|
Quality-Control Analytical Methods: Using Purified Water for Reconstitutions
Biller Jeremy
|
Jul/Aug 2011
Pg. 322-326
|
Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 50-53
|
Quality Control Analytical Methods: Refractive Index
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 43-47
|
Quality Assurance and Quality Control, Part 2
Akers Michael J
|
May/Jun 2015
Pg. 215-221
|
Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units
Sidhu Raman
|
Jul/Aug 2015
Pg. 307-310
|
Introduction to Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 481-484
|
Analytic Methods Used in Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 31-37
|
Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory
Ashworth Lisa D, Gordon Dana, Leiter Charles W, Snow Whit
|
Mar/Apr 2002
Pg. 149-150
|
Analytical Testing Facilities and Products
Hudson Sonora
|
Jul/Aug 2001
Pg. 284-286
|
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 479-485
|
Quality-Control Analytical Methods: Refractometry
Allen Loyd V Jr
|
Sep/Oct 2003
Pg. 383-385
|
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters
Dawson Michael E
|
Jul/Aug 2010
Pg. 317-320
|
Quality-Control Analytical Methods: Compounding Slow-Release Pharmaceuticals
Vu Nicole, Kupiec Thomas C, Raj Vishnu
|
Mar/Apr 2009
Pg. 144-145
|
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
|
Nov/Dec 2009
Pg. 540-543
|
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Vu Nicole
|
Mar/Apr 2007
Pg. 145-148
|
Quality Assurance and Quality Control, Part 1
Akers Michael J
|
Mar/Apr 2015
Pg. 121-124
|
Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis?
Zolner William J
|
May/Jun 2012
Pg. 226-229
|
Quality Control: 5 Steps to Improve Quality in the Compounding Lab
Zolner William J
|
Mar/Apr 2012
Pg. 136-144
|
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2
Cooper James F, Chakrabarty Kaushik, McGuire Jason, Zolner William J, Jones Vann, Hedman Hilary
|
Nov/Dec 2010
Pg. 493-506
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Rheologic Profile, Specific Gravity, Surface Tension, and pH of Fifteen Over-the-Counter Preparations
Al-Achi Antoine, Baghat Tushar, Chukwubeze Onah, Dembla Ishwin
|
May/Jun 2007
Pg. 252-258
|
Use, Standardization, Care of a pH Meter
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 116-117
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 305-309
|
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 397-402
|
Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding
Allen Loyd V Jr
|
May/Jun 2018
Pg. 206-217
|
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm!
Odegard Russell D
|
Mar/Apr 2008
Pg. 130-135
|
Quality Control: Can Compounding Pharmacy Learn from the Automotive Industry?
Dillon L Rad
|
Nov/Dec 2014
Pg. 475-477
|
Analytical Testing of Extemporaneously Compounded Preparations
Kupiec Thomas C
|
Mar/Apr 2000
Pg. 105-107
|
Quality Control: Standard Operating Procedures--An Essential Tool for Developing Quality Preparations
Ashworth Lisa D
|
May/Jun 2007
Pg. 226-229
|
Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach
Odegard Russell D
|
Sep/Oct 2013
Pg. 393-399
|
Standard Operating Procedure: Quality Assessment for Injectable Solutions
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 406-407
|
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing
Allen Loyd V Jr
|
May/Jun 2019
Pg. 211-216
|
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 3: Developing a Program of Quality Assurance and Continuous Quality Improvement
Cabaleiro Joe
|
May/Jun 2008
Pg. 234-236
|
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations
Cooper James F
|
Jan/Feb 2011
Pg. 49-54
|
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1
Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug
|
Mar/Apr 2011
Pg. 133-144
|
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Schnatz Rick, Hernandex-Cardoso Antonio
|
May/Jun 2011
Pg. 224-232
|
Quality Control: Analytical Methods. Certificates of Analysis, Part 1
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 486-488
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 146-150
|
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding
Wiley TS, Odegard RD, Raden J, Haraldsen JT
|
Mar/Apr 2014
Pg. 162-168
|
Standing Together Fixing the Drug Quality and Security Act
Miller David G
|
Mar/Apr 2015
Pg. 104-106
|
A Process Verification Model for Quality Assurance in a Compounding Pharmacy
Zolner William J
|
May/Jun 2008
Pg. 247-251
|
The pH Value of Common Household Products Using Meters, Papers and Sticks
Zuckerman Carole L, Nash Robert A
|
Mar/Apr 1998
Pg. 137-138
|
Quality Assurance for Sterile Products
Kastango Eric S, Douglass Kate
|
Jul/Aug 2001
Pg. 246-253
|
Standard Operaing Procedure for the Quality Assessment of Nasal Solutions
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 306-307
|
The pH Value of Urea Solutions in Purified Water
Jejurkar Purvi, Nash Robert A
|
Jan/Feb 1998
Pg. 76
|
Experimental Multidisciplinary Approach Based on Compounded Capsule's Quality Evaluation for Pharmacy Undergraduate Courses
dos Santos Matheus Skrcek Ribeiro, de Lima Amanda Muniz dos Santos, Christoff Adriana de Oliveira, Teixeira Mariana Lopes, Carneiro Jaqueline
|
Mar/Apr 2021
Pg. 104-108
|
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
|
Mar/Apr 2021
Pg. 115-124
|
PostScription-Ensuring Compounding Excellence: Quality Control or Quality Assurance?
Kupiec Thomas C
|
Mar/Apr 2002
Pg. 160
|
Quality Control: From Record Keeping to Key Performance Indicators: Managing Quality in Compounding Pharmacies
Karime Braga Glaucia, Vieira Fonseca Maria Jose
|
Mar/Apr 2010
Pg. 136-139
|
Standard Operating Procedure for Quality Assessment of Parenteral Nutrition Products
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 380-381
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 322-328
|
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
Martin Matt
|
Nov/Dec 2018
Pg. 475-478
|
Documentation: Records and Reports
Akers Michael J
|
Sep/Oct 2017
Pg. 373-380
|
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
|
Sep/Oct 2018
Pg. 401-404
|
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons
James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
|
Sep/Oct 2011
Pg. 390-407
|
Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety
Prince Bryan, Lundevall Jeremy
|
May/Jun 2014
Pg. 222-226
|
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding
Hyde Tiffany D
|
Jan/Feb 2014
Pg. 46-52
|
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014
Pg. 123-130
|
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating
Kastango Eric S
|
Sep/Oct 2004
Pg. 393-397
|
Quality in Pharmacy: The New Zealand Experience
Hamilton Pauline
|
Sep/Oct 2002
Pg. 354-358
|
The Cost of Quality in Pharmacy
Kastango Eric S
|
Nov/Dec 2002
Pg. 404-407
View Sample |
Home Infusion Accreditation: Another Quality Recognition Branding Tool
Canally Sandra C
|
Sep/Oct 2010
Pg. 360-364
|
Literature Review & Importance of Quality Control
Williams LaVonn A
|
Jan/Feb 2010
Pg. 54-56
|
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria
|
Nov/Dec 2009
Pg. 532-536
|
Establishing a Quality-Assurance Program for Hospital Compounding
McElhiney Linda F
|
Mar/Apr 2008
Pg. 116-120
|
PreScription: Quality Improvement in Pharmaceutical Compounding
Allen Loyd V Jr
|
May/Jun 2010
Pg. 180
|
Lessons Learned from a Continuous Quality-Improvement Testing Program
McElhiney Linda F
|
Sep/Oct 2011
Pg. 372-374
|
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 92
|
Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting
Medi-Dose Inc./EPS Inc.
|
Sep/Oct 2017
Pg. 384-387
|
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Donnelly Ronald F
|
Sep/Oct 2015
Pg. 383-386
|
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
|
Jul/Aug 2020
Pg. 322-326
|
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 299-303
|
Quality Control: Rapid Sterility Testing for Compounding Pharmacies
Taylor Andrew
|
Jul/Aug 2020
Pg. 299-303
|
Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding
Mulder Kyle
|
May/Jun 2021
Pg. 211-216
|
Quality Control: Photodocumentation in Pharmacy Compounding
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 116-117
|
Quality Assurance: Compounding Record Audits for Error Prevention
Hawkins Jessica
|
May/Jun 2023
Pg. 211-217
|
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 486-488
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2009
Pg. 234-238
|
Standard Operating Procedure: Denver Instrument Company M-120 Analytical Balance--Calibration, Cleaning, and Use
Allen Loyd V Jr
|
Sep/Oct 2005
Pg. 382-383
|
Testing of Estradiol in a Compounded Cream and a Stock Solution
Buderer Matthew J, Buderer Nancy M
|
Jan/Feb 2009
Pg. 74-77
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2008
Pg. 136-144
|
PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor
Gupta Vishnu D
|
Jul/Aug 2001
Pg. 328
|
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions
Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
|
Mar/Apr 2018
Pg. 164-171
|
Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website
Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
|
May/Jun 2019
Pg. 238-244
|
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Sep/Oct 2019
Pg. 387-391
|
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Nov/Dec 2019
Pg. 467-471
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
Quality Control: Photostability of Compounded Preparations
Allen Loyd V Jr
|
May/Jun 2020
Pg. 200-205
|
Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 312-313
|
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 56-57
|
Standard Operating Procedure for Physical Quality Assessment of Ointments/Creams/Gels
Allen Loyd V Jr
|
Jul/Aug 1998
Pg. 308-309
|
Standard Operating Procedure for Quality Assessment of Powder-Filled, Hard-Gelatin Capsules
Allen Loyd V Jr
|
May/Jun 1999
Pg. 232-233
|
Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 146-147
|
Some Quality Control Tests on Chromium Picolinate in Solid Dosage Forms
Al-Achi Antoine, Greenwood Robert, Beasley Shawn
|
Sep/Oct 1997
Pg. 349-351
|
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study
Santoveña A, Llabrés M, Fariña JB
|
Sep/Oct 2010
Pg. 430-435
|
Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 118-124
|
Quality Control: Water Activity Considerations for Beyond-use Dates
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 288-293
|
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
|
Mar/Apr 2018
Pg. 129-134
|
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 2
James Kate, Van Houtte Olivier, Ruriani Deborah, Nolan Odette, Corbetti Reto
|
Sep/Oct 2012
Pg. 396-403
|
E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project
Reed-Kane Dana, Kittell Katrina, Adkins Jacquelyn, Flocks Sarah, Nguyen Thu
|
Jan/Feb 2014
Pg. 83-86
|
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 1
Zatarski Monica, Nolan Odette, Corbetti Reto
|
Jul/Aug 2012
Pg. 312-320
|
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014
Pg. 305-310
|
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 477-479
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 490-496
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification
Allen Loyd V Jr
|
May/Jun 2012
Pg. 230-234
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 328-331
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control
Okeke Claudia C, Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 60-64
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 322-329
|
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison
Chauhan Harsh, Atef Eman
|
Jul/Aug 2009
Pg. 342-344
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Jul/Aug 2021
Pg. 298-302
|
A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies
Hall Essence, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
|
May/Jun 2021
Pg. 197-204
|
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 30-37
|
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
|
May/Jun 2022
Pg. 219-228
|
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials
Storme-Paris Isabelle, Storme Thomas, Thauvin Maxime, Brion Francoise, Chaminade Pierre, Rieutord Andre
|
Jan/Feb 2009
Pg. 81-86
|
Three Drug Stability Lives
Newton David W
|
May/Jun 2000
Pg. 190-193
|
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals
Meek Claudia, Rothardt Andrew, Evans Jason, Thurman Rosanne, Ashworth Lisa, Leff Richard
|
Jul/Aug 2015
Pg. 340-343
|
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment
Hecq Jean-Daniel, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Nov/Dec 2015
Pg. 521-524
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 42-45
|
Standarized Compounding: The Importance of Doing it the Same Way Every Time
Dillon L Rad
|
Mar/Apr 2015
Pg. 109-112
|
New England Compounding Center Indictment
Cabaleiro Joe
|
Mar/Apr 2015
Pg. 94-102
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Validation of the Technological Process of the Preparation "Milk by Vidal"
Savchenko LP, Mishchenko VA, Georgiyants VA
|
Nov/Dec 2017
Pg. 513-517
|
Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland
Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
|
Nov/Dec 2017
Pg. 518-529
|
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success
Pritchett Jon, Mixon William, O'Connell Kevin
|
Jan/Feb 2016
Pg. 29-36
|
Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, do Carmo Garcez Maria
|
Mar/Apr 2012
Pg. 98-102
|
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment
Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
|
Sep/Oct 2013
Pg. 432-435
|
Standard Operating Procedure: Testing of Water Supply: Barnstead D4751 High Purity Water System
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 296-297
|
Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network
Levitt Jonathan E, Mizeski Todd
|
Mar/Apr 2010
Pg. 134
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2010
Pg. 142-149
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C, Allen Loyd V Jr
|
May/Jun 2010
Pg. 232-238
|
Putting the Science Back into the "Art and Science" of Compounding
Kastango Eric S
|
Jul/Aug 2006
Pg. 263-268
|
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study
Peters Gregory F, McKeon Marghi R, Nerbun Richard G
|
Nov/Dec 2007
Pg. 450-470
|
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2007
Pg. 314-323
|
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations
Piette Marie, Stassen Thibaut, Kinget Renaat, Delattre Luc
|
Nov/Dec 2006
Pg. 469-477
|
Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 129-136
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Sep/Oct 2021
Pg. 389-395
|
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
|
Jan/Feb 2019
Pg. 47-49
|
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Miller David G
|
Jan/Feb 2014
Pg. 35-36
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 405-414
|
Quality Control: Undecided About Buying an In-House Water Purification System? Pros, Cons, and Caveats That May Provide the Answers You Need
Mixon William, Fox Samantha, Barnes Danny, Stuart William, Betlach Verne, Hall Richard M, Biller Jeremy, Kelly Russ, Janik Peter, Purcell Julian
|
Nov/Dec 2011
Pg. 480-487
|
Ammonium Chloride 5-mEq/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 501
|
Indigo Carmine Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 329
|
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja, Krämer Irene, Kamin Wolfgang
|
May/Jun 2013
Pg. 254-261
|
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Puertos Enrique, Spencer Melissa
|
Jul/Aug 2015
Pg. 334-336
|
Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review
Cutaia Kara, Chablani Lipika, Zhao Fang
|
Nov/Dec 2018
Pg. 480-489
|
Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
|
Jul/Aug 2010
Pg. 276-282
|
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension
Al-Achi Antoine, Parekh Bhavita
|
Nov/Dec 2004
Pg. 492-495
|
Parenteral Nutrition Equipment and Devices
Bertch Karen E
|
Sep/Oct 1998
Pg. 338-341
|
Alkalizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 404-405
|
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C
Webster Andrew A, English Brett A, McGuire J Michael, Riggs Robert M, Lander Vickie, Buckle Thomas
|
Sep/Oct 1999
Pg. 412-414
|
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 466-467
|
New Perspectives on Vancomycin Use in Home Care, Part 1
Kastango Eric S, Hadaway Lynn
|
Nov/Dec 2001
Pg. 465-469
|
Compounding Ear, Nose and Throat Preparations
Allen Loyd V Jr
|
May/Jun 2000
Pg. 164-169
|
Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 122-125
|
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution
Kommanaboyina Brahmaiah, Lindauer Richard F, Rhodes Christopher T, Grady Lee T
|
Mar/Apr 2000
Pg. 146-149
|
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Gupta Vishnu D, Bailey RE
|
Jan/Feb 2000
Pg. 66-68
|
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
de Villiers Melgardt M, Narsai Kirti, van der Watt Jakkie G
|
Jan/Feb 2000
Pg. 72-75
|
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution
Peyron Florence, Elias R, Ibrahim E, Amirat-Combralier V, Bues-Charbit M, Balansard G
|
Jul/Aug 1999
Pg. 316-320
|
Omeprazole (Prilosec) in the Atypical Patient, Administration of
Kane Dana Lynn
|
Jan/Feb 1997
Pg. 13
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Needham Shawn, Needham Shane
|
Nov/Dec 2018
Pg. 466-468
|
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 282-285
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
|
May/Jun 2023
Pg. 223-229
|
Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 295-302
|
Excipients and Adverse Events
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 382-385
|
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 305-313
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Riepl Mike, Kaiser Joe
|
Jul/Aug 2023
Pg. 284-293
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 123-139
|
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
|
Jul/Aug 2022
Pg. 270-274
|
Compounding with Pracaxi Versus Copaiba Oil
Magutu Tom
|
Jul/Aug 2022
Pg. 277-281
|
Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 385-395
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution
Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha
|
Jan/Feb 2020
Pg. 69-76
|
Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review
Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
|
Jul/Aug 2020
Pg. 346-351
|
Contamination Control in Compounding Areas
Mulder Kyle, Gonzales Ben A
|
Jul/Aug 2019
Pg. 271-278
|
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Newton David W
|
Jul/Aug 2019
Pg. 281-287
|
Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future
Brunner Scott
|
Jul/Aug 2019
Pg. 294-296
|
Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development
Orubu Ebiowei Samuel F, Patani Bernard Opatimidi, Arhewoh Matthew Ikhuoria
|
Nov/Dec 2021
Pg. 475-481
|
The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report
Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
|
Mar/Apr 2022
Pg. 110-115
|
Compounding for Investigational and Clinical Studies
Allen Loyd V Jr
|
May/Jun 2022
Pg. 201-209
|
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
|
Sep/Oct 2021
Pg. 358-362
|
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
|
Sep/Oct 2021
Pg. 364-371
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies
Polonini Hudson, Dijkers Eli CF, Ferreira Anderson O, da Silva Sharlene L, Araújo Paulo Victor C, Koulouridas Savvas
|
Sep/Oct 2020
Pg. 426-433
|
Cleanroom Cleanliness
Mulder Kyle
|
Jan/Feb 2021
Pg. 6-12
|
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg, Yoch Doug
|
Jan/Feb 2021
Pg. 18-23
|
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg, Yoch Doug
|
Mar/Apr 2021
Pg. 94-98
|
Compounded Suppositories and Pharmaceutical Care
Duncan-Hewitt Wendy, Rains John
|
Mar/Apr 1997
Pg. 93-99
|
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
|
Jan/Feb 2001
Pg. 9-12
|
Basics of Compounding Biotechnologic Preparations
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 34-37
|
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding
Kastango Eric S, Douglass Kate
|
Jul/Aug 1999
Pg. 253-258
|
Compounding Intrathecal Medications
Vidrine Eric
|
Jan/Feb 2000
Pg. 24-25
|
Marketing Your Prescription Compounding Practice: Part Two
Letendre William R, Jackson Richard A
|
Mar/Apr 2000
Pg. 115-117
|
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 126-127
|
The BPS Pharmacy Specialty Certification Program
Bertin Richard J
|
May/Jun 1999
Pg. 200-203
|
The Basics of Compounding Emulsions, Part 2
Allen Loyd V Jr
|
May/Jun 2001
Pg. 198-201
|
Basics of Compounding: Clinical Studies
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 443-447
|
Using ACDs in the Practice of Pharmacy
Kastango Eric S
|
Jan/Feb 2005
Pg. 15-21
|
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729>
Driscoll David F, Nehne Jorg, Horst Peterss, Klutsch Karsten, Bistrian Bruce R, Wilhelm Niemann
|
Jul/Aug 2006
Pg. 309-315
|
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations
Douglass Kate
|
Jul/Aug 2006
Pg. 253-261
|
Pharmacy Compounding Urban Legends
Kastango Eric S
|
Jan/Feb 2006
Pg. 32-34
|
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations
Dawson Michael F
|
Jan/Feb 2006
Pg. 36-39
|
The Story of Hospice
Kuntz Rachael
|
Mar/Apr 2006
Pg. 100-102
|
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding
McElhiney Linda F
|
Nov/Dec 2009
Pg. 525-530
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures
Okeke Claudia C, Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 546-553
|
PreScription: Geriatric Compounding: An Opportunity for Pharmacists
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 492
|
PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective
Guedes de Souza Hugo, do Carmo Garcez Maria, Pinheiro Vanessa A
|
Jan/Feb 2009
Pg. 87-88
|
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Mixon Bill, Ille Gary
|
Jul/Aug 2009
Pg. 290-294
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2008
Pg. 344-353
|
Identifying the Criteria of a Valid Stability Study
Williams LaVonn A, Hastings Mitchell Blaine
|
Jan/Feb 2009
Pg. 32-36
|
PreScription: Compounding Around the World
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 382
|
Calculations
Stockton Shelly J
|
Sep/Oct 2008
Pg. 444-445
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2008
Pg. 440-443
|
PostScription: The International Society of Pharmaceutical Compounding: A Discussion of Its Importance from the Perspective of ISPhC Leadership
Marro Diego, Barbosa Carlos Mauricio
|
Sep/Oct 2008
Pg. 467
|
Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 381
|
Equipment, Supplies, and Facilities Required for Hospital Compounding
McElhiney Linda F
|
Nov/Dec 2006
Pg. 436-441
|
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions
Allen Loyd V Jr
|
May/Jun 2006
Pg. 218
|
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration
Kupiec Tom, Kemp Jesse
|
Jul/Aug 2007
Pg. 326-327
|
Statistical Analysis of Barrier Isolator/Glovebox Glove Failure
Park Young H, Pines E, Ofouku M, Cournoyer ME
|
Jul/Aug 2007
Pg. 338-346
|
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 2: Developing Essential Standard Operating Procedures
Cabaleiro Joe
|
Sep/Oct 2007
Pg. 397-398
|
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2007
Pg. 230-236
|
Records and Record-Keeping for the Hospital Compounding Pharmacist
McElhiney Linda F
|
Mar/Apr 2007
Pg. 138-143
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics
Allen Loyd V Jr, Okeke Claudia C
|
Nov/Dec 2007
Pg. 492-499
|
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
|
Jul/Aug 2007
Pg. 302-305
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|
The Internet on Steroids: How Connected is Your Pharmacy?
Felkey Bill G
|
Nov/Dec 2007
Pg. 445-448
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2008
Pg. 252-257
|
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
|
May/Jun 2008
Pg. 216-229
|
Communication with Pharmacy Technicians: How to Reduce Stress and Improve Pharmacy Operations
Fyke Jeremy P, Hoffman Mary F
|
May/Jun 2008
Pg. 230-233
|
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care
Murry Tom
|
Mar/Apr 2008
Pg. 174-175
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2008
Pg. 54-60
|
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Jan/Feb 2008
Pg. 74-82
|
An Outlook on the European and Italian Rules to Guarantee Magistral Formulas
Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
|
Jan/Feb 2019
Pg. 6-12
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
|
Jan/Feb 2019
Pg. 23-31
|
Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 35-44
|
PreScription: 2017--Some Good Things Happened and Some Others
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 4
|
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives
Blankenship Cynthia
|
Jan/Feb 2018
Pg. 26-28
|
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing
Blankenship Cynthia
|
Mar/Apr 2018
Pg. 125-126
|
IACP Legislative/Regulatory Update
International Academy of Compounding Pharmacists
|
Sep/Oct 2017
Pg. 382-383
|
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Sep/Oct 2016
Pg. 416-420
|
The International Academy of Compounding Pharmacists Introduces a New President
Rice Baylor
|
Mar/Apr 2017
Pg. 116-117
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 495-500
|
PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 4
|
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Ligugnana Roberto
|
May/Jun 2017
Pg. 182-190
|
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William, Roth Abby
|
May/Jun 2017
Pg. 193-203
|
Component Selection for Sterile Compounding
Dilzer Richard H
|
Jul/Aug 2017
Pg. 277-280
|
The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871
Rice Baylor
|
Jul/Aug 2017
Pg. 290-291
|
Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 293-298
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Basics of Sterile Compounding: Particulate Matter
Akers Michael J
|
Sep/Oct 2017
Pg. 395-404
|
Orodispersible Films for Compounding Pharmacies
Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
|
Nov/Dec 2017
Pg. 454-461
|
Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!
Blankenship Cynthia
|
Nov/Dec 2017
Pg. 468
|
PreScription: 2014 in Review
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 4
|
PreScription: Déjà Vu All Over Again
Allen Loyd V Jr
|
May/Jun 2014
Pg. 180
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Allen Loyd V
|
Jul/Aug 2015
Pg. 280-287
|
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015
Pg. 377-380
|
Basics of Compounding: The "Negative" List
Allen Loyd V
|
Jul/Aug 2015
Pg. 311-313
|
PostScription: The Home Field Advantage
Cabaleiro Joe
|
Jan/Feb 2016
Pg. 86-87
|
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations
McCrory Gary
|
Mar/Apr 2016
Pg. 95-96
|
Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha, Harger Beau, Estrada Nick
|
Jul/Aug 2016
Pg. 277-280
|
IACP's 2016 Compounders on Capitol Hill Asks
|
Jul/Aug 2016
Pg. 294-296
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard!
Voliva John
|
Sep/Oct 2016
Pg. 377-378
|
PostScription: Pharmacy Fellowship Program: Building a Stronger Profession
Bernardi Steve
|
Nov/Dec 2015
Pg. 525
|
Microbial Identification in Pharmaceutical Compounding
Hyde Tiffany, Anstead James, Schade Lisa, Zellner James
|
Jan/Feb 2016
Pg. 13-18
|
Basic Principles of Lyophilization, Part 2
Akers Michael J
|
Jan/Feb 2016
Pg. 20-27
|
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 389-390
|
PreScription: The Documented Past and the Exciting Future
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 442
|
Root Cause Analysis, Part 1: Nonsterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Nov/Dec 2015
Pg. 465-469
|
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 356
|
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
May/Jun 2013
Pg. 238-246
|
Basics of Compounding: Repackaging, Part 2
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 136-140
|
Decontamination Technology: The Missing Element
Rahe Hank
|
May/Jun 2013
Pg. 193-199
|
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
Brensel Robert, Brensel Scott, Ng Amy
|
Nov/Dec 2013
Pg. 465-475
|
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 4
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
|
Jan/Feb 2014
Pg. 14-19
|
Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding
Hoffmann Brittany, Carlson Christie, Rao Deepa A
|
Jul/Aug 2014
Pg. 341-344
|
PostScription: Responsibilities of a Compounding Pharmacist
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 351
|
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know
Lanze Amanda, Rudner Shara
|
Sep/Oct 2014
Pg. 397-399
|
Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 401-404
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill
Miller David G
|
Jul/Aug 2014
Pg. 302
|
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D, Daniels Kelly R
|
Jan/Feb 2014
Pg. 70-77
|
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Timko Robert J, Crooker Philip EM
|
Mar/Apr 2014
Pg. 101-111
|
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities
Miller David G
|
Mar/Apr 2014
Pg. 117-118
|
E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy
Reed-Kane Dana, Vasquez Kellie, Pavlik Aaron, Pergine Johanna, Sandberg Michelle
|
Mar/Apr 2014
Pg. 159-161
|
International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives
Miller David G
|
Jan/Feb 2013
Pg. 48-49
|
PostScription: Rules for Pharmaceutically Elegant Calculations
Stockton Shelly J
|
May/Jun 2012
Pg. 262-263
|
Palliative Care and Compounding for Household Pets
Gaskins Jessica L
|
Nov/Dec 2012
Pg. 452-455
|
Beyond-use Date: Establishment and Maintenance
Osteen Richard
|
Nov/Dec 2012
Pg. 471-474
|
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 2
Haile Michael, Anderson Kim, Evans Alex, Crawford Angela
|
Mar/Apr 2012
Pg. 104-109
|
Calculations
Stockton Shelly J
|
Nov/Dec 2011
Pg. 498
|
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone
Cabaleiro Joe
|
Jan/Feb 2012
Pg. 86-87
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 64-68
|
PostScription: Compounders Go Above and Beyond in the Name of Safety
Gates Ernest P Jr
|
Sep/Oct 2011
Pg. 438-439
|
The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire
Miller David G
|
Nov/Dec 2011
Pg. 474-479
View Sample |
PreScription: American Pharmacists Month: A Time for Taking Responsibility
Menighan Thomas E
|
Sep/Oct 2011
Pg. 356
|
In the Hands of Your Enemy
Worthen Dennis B
|
Nov/Dec 2010
Pg. 456-462
|
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management
Robinson Marian
|
Jan/Feb 2011
Pg. 20-26
|
Compounding In Crisis:The Aftermath of Hurricane Katrina
Vail Jane
|
Jan/Feb 2007
Pg. 28-35
|
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now?
Miller David G
|
Nov/Dec 2013
Pg. 480-481
|
Return to Top |